Privacy statement

The Nominated Third Party will collect, use, store and/or disclose personal information relating to you in connection with the Program, for purposes of administering your involvement in the Program. The Nominated Third Party uses your personal information primarily to manage your participation in the Program and for other purposes as notified to you. The Nominated Third Party will not use your personal information for any other purposes unless the Nominated Third Party has your consent to do so or is required to do so by law. If you do not provide personal information when requested, the Nominated Third Party will not be able to manage your participation in the Program and, as a result, you may not be able to participate. The Nominated Third Party takes reasonable steps to protect such personal information from misuse, interference, loss and unauthorized access, modification or disclosure.

Your personal information will be handled in accordance with the Privacy Policy which details (amongst other things) how you can access, correct or complain about the handling of your personal information, and how the Nominated Third Party will respond to your requests or complaints.

If you have any questions or if you would like a copy of the Privacy Policy, or if you would like to see, correct or delete your records or if you have any queries or complaints, please contact the Nominated Third Party by calling 1800 626 752 or writing to The Man Plan, Reply Paid 751, North Sydney NSW 2059 (no stamp required) or fax to 1800 219 836.

Before you submit any information and agree to enrol in the Program, you should be aware of and consent to the following:

FOR PATIENTS CONSENT: By providing your personal information (including your name, age, contact details; as well as, sensitive information relating to your condition being treated with LUCRIN), you consent to the Nominated Third Party collecting and using your personal information in accordance with the Program Terms and Conditions and the Privacy Policy in connection with the administration and management of the Program. In particular, you consent to a representative of the Nominated Third Party contacting you to confirm your consent to participate in the Program and your acceptance of the Program Terms and Conditions and the Privacy Policy.

COLLECTION AND USE OF YOUR PERSONAL INFORMATION: The Nominated Third Party may collect personal information directly from you, and also from your Prescribing Specialist, the Prescribing Specialist's Nominated Users as well as third parties involved in the delivery of the Program (e.g. EPs, HCs or Dieticians etc.). Your personal information will be stored in a Program database via which it will be accessible by your Prescribing Specialist and their Nominated Users in accordance with the Program Terms and Conditions and the Privacy Policy. The Nominated Third Party may also disclose your personal information to other persons involved with the Program, such as third party service providers, in accordance with the Privacy Policy. The Nominated Third Party may use your personal information to contact you as necessary to clarify certain aspects of your personal information and I or to review your experience regarding treatment of your condition(s), participation in the Program, and your interest in participating in market research.

DATA SHARING WITH ABBVIE: Any reported adverse events that arise from taking LUCRIN will be reported to AbbVie for the purpose of reporting this information to the appropriate regulatory notification body and/or in accordance with AbbVie's adverse event reporting processes. AbbVie Pharmacovigilance may contact your HCP for further information regarding any reported Adverse Events. Otherwise, de-identified information relating to your participation in the Program will be collated into a report for AbbVie. AbbVie may use this information for analysis and research purposes (e.g. to calculate patient adherence rates) and may disclose the information to third parties in order to publish the information in reports or medical publications. Any personal information collected by AbbVie will be handled in accordance with AbbVie’s privacy policy available at http://www.abbvie.com.au/privacy/home.html.

FOR PRESCRIBING SPECIALISTS AND HEALTHCARE PROFESSIONALS CONSENT: In completing your enrolment to participate in the Program, you consent to the Nominated Third Party, collecting and using the personal information you provide regarding yourself (e.g. name and contact details) to contact you in relation to the Program, including patient-related updates, and otherwise as necessary to undertake the Program.

WEB PORTAL: The Web Portal can only be accessed by secure login upon registration. Prescribing Specialists are designated a master account ("Master Account") which provides access, to:

a) the "FasTrack Enroller", an online tool that allows Prescribing Specialists and their Nominated Users to refer patients for enrolment in the Program; and

b) Additional information, including but not limited to, LUCRIN Product Information, PBS Information, Minimum Product Information, Consumer Medical Information, these Terms and Conditions, The Man Plan Privacy Policy.

During the registration process, an AbbVie Sales Representative will offer the Prescribing Specialist the opportunity to nominate additional users, Nominated Users. The Prescribing Specialist acknowledges that he/she is authorised, and has provided all necessary notifications to, or obtained consents from the Nominated Users to be linked to the Prescribing Specialist's Master Account. Prescribing Specialists will not have access to any other Prescribing Specialist's information or patient data. Prescribing Specialists' names, contact details, total number of patient enrolments, and channel of enrolment will be collected and collated into a report for AbbVie, for the purposes of planning and managing resources for the Program. Patient details and personal information will not be included in any report provided to AbbVie. Any personal information collected by AbbVie will be handled in accordance with AbbVie's privacy policy available at http://www.abbvie.com.au/privacy/home.html

PERSONAL DATA OF PATIENTS: If you are a Prescribing Specialist or a Nominated User, you confirm that you are authorised by, and have provided all necessary notifications to, each patient you are nominating for enrolment (or their guardian(s) to permit you to collect that patient's personal information and provide this to the Nominated Third Party for the Nominated Third Party to use and disclose in accordance with The Man Plan terms and conditions and The Man Plan Privacy Policy. You confirm that you have informed such patients that the Nominated Third Party will contact them via telephone/mail to complete their enrolment process.

Date of preparation: May 2019

AU-LUCR-180043.